Within obese populations, upper body fat distribution, increased liver fat content, hypertension, hyperglycemia and dyslipidemia (known collectively as the metabolic syndrome), have been shown to confer lower insulin clearance [5, 8–12]. This evidence concerns the gene INS and Hyperglycemia.